Related Experiment Videos
Brief information on an early phase-II study with deprenyl in demented patients
E Martini1, I Pataky, K Szilágyi
1National Institute of Nervous and Mental Disease, Budapest, Hungary.
Pharmacopsychiatry
|November 1, 1987
Abstract:
Eleven elderly female patients (73-88 yrs) suffering from senile dementia of Alzheimer type (7 cases) and from multi-infarct dementia (4 cases) were treated with (-) deprenyl (Jumex) for 3 and 6 months respectively. Improvement was most frequent in SDAT patients and most pronounced as regards self-care, short-term memory, mental alertness and uncooperativeness.